We are a clinical-stage pharmaceutical company focused on the discovery, development and subsequent commercialization of novel, first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases.
Last Closing Price
J.P. Morgan, Jefferies, Leerink Partners, Canaccord Genuity, JMP Securities, H.C. Wainwright & Co., Baird
To view the prospectus for Karyopharm Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277